newsfeed-en
@SachsAssociates
17. May 2022 via Twitter
e-Meet Mike at #Sachs_IOIFMore info @ https://t.co/08rXthnHxk#Sachs_IOIF #Virtualconference #Virtual #Digitalconference #lifesciences #partnering #businessdevelopment #bd #licensing #health #investment #startup #healthcare #innovation #biotech #medtech @lumanity pic.twitter.com/W1bpzy1gJy— Sachs Associates (@SachsAssociates) May 17, 2022
@SachsAssociates
17. May 2022 via Twitter
Paul Rennert is a noted scientist and biotechnology executive with strong strategic and leadership experience. e-Meet Paul at #Sachs_IOIFMore info @ https://t.co/08rXthnHxk@PDRennert @BioAleta pic.twitter.com/eVhyT9618J— Sachs Associates (@SachsAssociates) May 17, 2022
@eurocrowd
17. May 2022 via Twitter
More panelists confirmed for #CrowdCamp2022!Experts from @EMEAorg, @ucl and Bizkaia Crowdfunding will discuss the best practices for incentivising #ESG reporting❗️Check the agenda https://t.co/4ZpkMLVKtO ✍️Register https://t.co/OxkRT9rJSn pic.twitter.com/CFc8TH4tSq— EUROCROWD (@eurocrowd) May 17, 2022
@SachsAssociates
17. May 2022 via Twitter
Roger Longman is co-founder and chairman of Real Endpoints LLC, a leading reimbursement-focused analytics and advisory firm.e-Meet Roger at #Sachs_IOIFMore info @ https://t.co/08rXthnHxk@RealEndpoints @RealEndptsRog pic.twitter.com/wfA2UYD4RW— Sachs Associates (@SachsAssociates) May 17, 2022
@SachsAssociates
16. May 2022 via Twitter
Ammar Qadan(@AmmarQadan) is Vice President and Head of Global Market Access at @illumina, a company whose mission is “to improve human health by unlocking the power of the genome”.e-Meet Ammar at #Sachs_IOIFMore info @ https://t.co/08rXthnHxk pic.twitter.com/7o0TIfhO7O— Sachs Associates (@SachsAssociates) May 16, 2022
@SachsAssociates
16. May 2022 via Twitter
We are pleased to announce Breakthroughs in Neurostimulation & Rehabilitation Panel lineup, which will happen during Sachs - Biopôle Investment Seminar #SBISS on 16th of June.More info @ https://t.co/aE6pqtusdB#SBISS #cns pic.twitter.com/MRYwUXPpFK— Sachs Associates (@SachsAssociates) May 16, 2022
@eurocrowd
13. May 2022 via Twitter
This is not true. Only German and French platforms seek an extension that would create confusion for retail investors and increase supervisory burden. In other EU member states platforms are preparing and have submitted license requests. https://t.co/tDYPTrOAJJ via @AgefiFrance— EUROCROWD (@eurocrowd) May 13, 2022
@SachsAssociates
12. May 2022 via Twitter
We are pleased to announce, Biopôle, with the support of the Canton of Vaud has partnered up with Sachs Associates to organize three investment focused seminars in 2022. Registration for Investors is already open.More info @ https://t.co/aE6pqtusdB#SBISS pic.twitter.com/34Tnk7q40A— Sachs Associates (@SachsAssociates) May 12, 2022
@eurocrowd
12. May 2022 via Twitter
Learn more about ECSP for other alternative investment forms on #CrowdCamp2022Panelists from @_EVPA_ @LumoFrance @Innovestment and @EBAN_org will discuss the interconnection of private funding tools❗️Check the agenda https://t.co/4ZpkMLVKtO ✍️Register https://t.co/OxkRT9rJSn pic.twitter.com/NUSzJQcqob— EUROCROWD (@eurocrowd) May 12, 2…
@eurocrowd
11. May 2022 via Twitter
📣Here are the first panelists for the #CrowdCamp2022Experts from @goparity, @Oneplanetcrowd and @Ecrowdinvest will discuss #crowdfunding in the future of #sustainablefinance❗️Check out the agenda https://t.co/4ZpkMLVKtO✍️Register https://t.co/OxkRT9rJSn pic.twitter.com/RyLqazu7Rk— EUROCROWD (@eurocrowd) May 11, 2022